Kankakee, IL, United States of America

Judith A Vollmer-Gash

This inventor holds 1 USPTO granted patent. Top assignee: Serologicals Royalty Company. Active years: 2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Judith A Vollmer-Gash. Retrieved from https://idiyas.com/inventor/judith-a-vollmer-gash

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Judith A Vollmer-Gash: Innovator in Prion Inactivation

Introduction

Judith A Vollmer-Gash is a notable inventor based in Kankakee, IL (US). She has made significant contributions to the field of biotechnology, particularly in the treatment of lipoproteins. Her innovative work focuses on the inactivation of prions, which are infectious agents that can cause serious diseases.

Latest Patents

Judith holds a patent for a process titled "Process for inactivating prions in lipoproteins." This patent describes a method for treating purified lipoprotein material to effectively inactivate prions without adversely affecting the biological activity of the lipoprotein. The process involves treating the lipoprotein prion composition with a solution of base at a pH between 10 and 13 for a sufficient duration to achieve inactivation.

Career Highlights

Judith is associated with Serologicals Royalty Company, where she applies her expertise in biotechnology. Her work has been instrumental in advancing methods for ensuring the safety and efficacy of lipoprotein treatments.

Collaborations

Judith has collaborated with notable colleagues, including Joseph G Montalto and Thomas M McCall. These partnerships have contributed to her innovative research and development efforts.

Conclusion

Judith A Vollmer-Gash is a pioneering inventor whose work in prion inactivation has the potential to impact the field of biotechnology significantly. Her contributions continue to advance the understanding and treatment of infectious agents in lipoproteins.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…